Oppenheimer & CO Inc Illumina, Inc. Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Illumina, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 40,887 shares of ILMN stock, worth $5.56 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
40,887
Previous 51,311 20.32%
Holding current value
$5.56 Million
Previous $5.36 Million 0.45%
% of portfolio
0.08%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$105.28 - $135.9 $1.1 Million - $1.42 Million
-10,424 Reduced 20.32%
40,887 $5.33 Million
Q2 2024

Aug 07, 2024
SELL
$101.05 - $133.57 $52,849 - $69,857
-523 Reduced 1.01%
51,311 $5.36 Million
Q1 2024

May 06, 2024
BUY
$127.73 - $147.2 $1.28 Million - $1.48 Million
10,050 Added 24.05%
51,834 $7.12 Million
Q4 2023

Feb 13, 2024
SELL
$92.79 - $142.53 $1.28 Million - $1.97 Million
-13,821 Reduced 24.86%
41,784 $5.82 Million
Q3 2023

Nov 07, 2023
SELL
$128.91 - $192.44 $237,065 - $353,897
-1,839 Reduced 3.2%
55,605 $7.63 Million
Q2 2023

Aug 02, 2023
SELL
$183.43 - $232.67 $17,425 - $22,103
-95 Reduced 0.17%
57,444 $10.8 Million
Q1 2023

May 10, 2023
BUY
$193.75 - $232.55 $230,175 - $276,269
1,188 Added 2.11%
57,539 $13.4 Million
Q4 2022

Feb 07, 2023
SELL
$187.24 - $242.74 $975,520 - $1.26 Million
-5,210 Reduced 8.46%
56,351 $11.4 Million
Q3 2022

Nov 14, 2022
SELL
$177.23 - $227.44 $815,080 - $1.05 Million
-4,599 Reduced 6.95%
61,561 $11.7 Million
Q2 2022

Aug 08, 2022
SELL
$181.58 - $368.0 $184,122 - $373,152
-1,014 Reduced 1.51%
66,160 $12.2 Million
Q1 2022

May 12, 2022
SELL
$303.87 - $423.8 $445,777 - $621,714
-1,467 Reduced 2.14%
67,174 $23.5 Million
Q4 2021

Feb 02, 2022
SELL
$347.28 - $421.83 $27,782 - $33,746
-80 Reduced 0.12%
68,641 $26.1 Million
Q3 2021

Nov 12, 2021
BUY
$405.61 - $524.84 $278,248 - $360,040
686 Added 1.01%
68,721 $27.9 Million
Q2 2021

Aug 03, 2021
SELL
$372.84 - $481.5 $148,390 - $191,637
-398 Reduced 0.58%
68,035 $32.2 Million
Q1 2021

May 10, 2021
SELL
$361.28 - $504.76 $9.63 Million - $13.5 Million
-26,647 Reduced 28.03%
68,433 $26.3 Million
Q4 2020

Feb 11, 2021
SELL
$292.7 - $370.96 $1.4 Million - $1.77 Million
-4,784 Reduced 4.79%
95,080 $35.2 Million
Q3 2020

Nov 13, 2020
BUY
$268.51 - $400.74 $4.68 Million - $6.98 Million
17,412 Added 21.12%
99,864 $30.9 Million
Q2 2020

Aug 11, 2020
BUY
$256.46 - $373.01 $599,347 - $871,724
2,337 Added 2.92%
82,452 $30.5 Million
Q1 2020

May 08, 2020
SELL
$209.2 - $335.53 $335,347 - $537,854
-1,603 Reduced 1.96%
80,115 $21.9 Million
Q4 2019

Feb 07, 2020
SELL
$288.29 - $335.49 $1.18 Million - $1.37 Million
-4,086 Reduced 4.76%
81,718 $27.1 Million
Q3 2019

Oct 31, 2019
SELL
$266.84 - $378.23 $208,402 - $295,397
-781 Reduced 0.9%
85,804 $26.1 Million
Q2 2019

Aug 09, 2019
SELL
$300.59 - $368.15 $1.58 Million - $1.93 Million
-5,253 Reduced 5.72%
86,585 $31.9 Million
Q1 2019

Apr 24, 2019
SELL
$272.57 - $321.18 $3.66 Million - $4.31 Million
-13,425 Reduced 12.75%
91,838 $28.5 Million
Q4 2018

Jan 29, 2019
BUY
$272.46 - $366.54 $3.85 Million - $5.18 Million
14,141 Added 15.52%
105,263 $31.6 Million
Q3 2018

Oct 26, 2018
BUY
$279.04 - $367.06 $308,060 - $405,234
1,104 Added 1.23%
91,122 $33.4 Million
Q2 2018

Aug 10, 2018
SELL
$228.17 - $292.07 $106,783 - $136,688
-468 Reduced 0.52%
90,018 $25.1 Million
Q1 2018

May 01, 2018
BUY
$209.54 - $253.91 $167,003 - $202,366
797 Added 0.89%
90,486 $21.4 Million
Q4 2017

Feb 07, 2018
BUY
$202.23 - $230.03 $173,917 - $197,825
860 Added 0.97%
89,689 $19.6 Million
Q3 2017

Nov 09, 2017
BUY
$172.3 - $213.93 $15.3 Million - $19 Million
88,829
88,829 $17.7 Million

Others Institutions Holding ILMN

# of Institutions
900
Shares Held
137M
Call Options Held
1.22M
Put Options Held
1.43M
View Full List

About ILLUMINA, INC.

ILMN Quotes by TradingView
  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email